CANF peer analysis
Can-Fite BioPharma (CANF) against its competitors: price, today's move, 1-year return and market value side by side.
- CANF's peers: BDRX (Biodexa Pharmaceuticals), CLDI (Calidi Biotherapeutics), CMND (Clearmind Medicine), CNSP (CNS Pharmaceuticals), GRI (GRI Bio), JAGX (Jaguar Health), KZIA (Kazia Therapeutics), OGEN (Oragenics).
CANF and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BDRX Biodexa Pharmaceuticals | $1.95 | -2.26% | -98.74% | $181.86K |
| CLDI Calidi Biotherapeutics | $0.51 | -4.23% | -97.88% | $1.74M |
| CMND Clearmind Medicine | $3.04 | -0.82% | -99.53% | $1.54M |
| CNSP CNS Pharmaceuticals | $3.92 | -11.82% | -41.57% | $5.78M |
| GRI GRI Bio | $1.12 | -11.81% | -97.63% | $2.45M |
| JAGX Jaguar Health | $0.22 | -32.42% | -99.97% | $2.95M |
| KZIA Kazia Therapeutics | $5.05 | -5.96% | -34.75% | $8.18M |
| OGEN Oragenics | $0.17 | -8.99% | -82.77% | $776.06K |
| SILO Silo Pharma | $1.88 | -0.53% | -68.27% | $4.05M |
| SNGX Soligenix | $0.24 | -5.06% | -81.82% | $5.61M |
| CANF Can-Fite BioPharma | $1.47 | -2.69% | -77.80% | $1.92M |